* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Poster
Survey
Document related concepts
Transcript
Human Argonaute-2 (Ago-2) For All Your RNA Slicing Needs Evan Bruss, T.J. Davis, Jack Hermsen, Justin Johnson, Robert Laughlin, Maurice Lucré, Chad Marable, Brett Poniewaz, Virginia Tuncel, Gina Wade, Michael Weeden Teacher: David Sampe Mentor: Mark McNally, Ph.D., Medical College of Wisconsin, Microbiology and Molecular Genetics The Story of Human Argonaute-2 Human cells have the remarkable capability to regulate protein production by degrading target mRNA by two pathways: RNA interference (RNAi) and micro RNA (miRNA). Central to these pathways is the protein Argonaute-2 (Ago-2). In the RNAi pathway, small RNAs derived from viruses are used by Ago-2 to slice virus mRNA, protecting the cells from infection. In the miRNA pathway, Ago-2 utilizes naturally occurring miRNA to slice cellular mRNAs to control protein production. Ago-2 works by binding small (~22 nucleotide) regulatory RNAs (siRNA and miRNA) that target mRNA by base pairing. Ago-2 binds to the phosphate backbone of regulatory RNA within the RNA Interference Silencing Complex (RISC), which is then guided to the mRNA target by the regulatory RNA. The RNase domain of Ago-2 (containing His807, Asp669, Asp597, and Glu637 in its active site) then “slices” the target to initiate degradation. Researchers have found that they can make their own synthetic siRNA sequences to insert within cells that target a specific RNA of their choosing. This may reduce the level of diseasecausing proteins (for example, in breast cancer). Determining the structure of Ago-2 allowed researchers to understand how this enzyme functions in the siRNA/miRNA pathways to break down target RNA. The Brown Deer High School SMART (Students Modeling A Research Topic) Team has designed a model of Ago-2 using 3D printing technology to investigate its structure-function relationship. How Ago-2 Works siRNA Pathway miRNA Pathway 1a. In the small interfering RNA pathway (siRNA), a virus introduces its genetic material as double stranded RNA (dsRNA) into a cell. 1b. In the micro RNA pathway (miRNA), the DNA is transcribed into primary miRNA. Pri-miRNA is single stranded, but assumes a secondary structure in the form of a hairpin shape. 2a. A protein called Dicer dices 2b. Dicer converts pre-miRNA to miRNA. the dsRNA into 21-22 nucleotide segments. 3. The RNA unwinds, as only the antisense strand is used. Because Ago-2 recognizes and binds to the 21 nucleotide RNA on the backbone, it can grab any RNA of that size. The miRNA/siRNA targets the RNA-Induced Silencing Complex (RISC) to the mRNA where Ago-2 slices the mRNA towards the center of the RNA hybrid. 4a. The sliced portions of the 4b. Occasionally in the miRNA target RNA are quickly broken pathway, perfect base pairing is down into nucleotides by not achieved. In these special RNases in the cell. cases, an unknown mechanism stops translation of the target RNA, effectively inactivating it. The SMART Team Program is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number 8UL1TR000055. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Stabilization of the Domains of Ago-2 1a. Virus Implants dsRNA 1b. DNA Transcription of Pri-miRNA Virus Linear pri-miRNA Pri-miRNA Dicer Nucleus Pre-miRNA Drosha 2a. Formation of 2b. Formation of miRNA by Dicer siRNA by Dicer Ago-2 3. Slicing of Target RNA in RISC Does Ago-2 structure change upon miRNA binding? To determine if there was a change in Ago-2 structure, researchers used an approach called “protease sensitivity.” Differences in protease (thermolysin) accessibility determine structural changes that researchers can see using gel electrophoresis. In the experiment, thermolysin, was used to break down the protein into its domains. The results of the gel electrophoresis showed that several domains of Ago-2 were separated when miRNA was not present. When Ago-2 is bound to miRNA, the Ago-2 structure is stabilized and does not cleave into separate domains. Based on the experiment, there is a major structure change in Ago-2 when miRNA is bound. Ago-2 Domain Functions The PIWI domain acts as an RNase, slicing the target RNA into pieces. This domain contains the active site (His807, Asp669, Asp597, and Glu637) and comprises the area between amino acids 573 and 859. The PAZ domain holds the 3’ end of the template RNA. This domain is located between amino acids 226 and 347. The MID domain holds the 5’ end of the template RNA. This domain is located between amino acids 450 and 573. The N domain plays an important role in unwinding the RNA duplex during formation of RISC. This domain is located between amino acids 1 and 175. The L2 domain is a “linker” region between the PAZ and MID domains. It stretches from amino acid 347 to 450. RISC The target RNA binds to the PAZ and MID domains. When it is present, it helps to hold the domains of Ago-2 together. Conclusions 4a. RNase Degradation 4b. Translation Repressed Imperfect Base Pairing Ribosome Blockage Ago-2 has domain structures that include: PIWI, MID, PAZ, and the N-terminus. The MID and PAZ domains are oriented such that only ~21 nucleotide RNAs can bind. Ago-2 binds to the phosphate backbone of miRNA and siRNA so that the nucleotides can bind with complementarity to the target mRNA. The target mRNA gets “sliced” at the PIWI domain because the active site within it acts like an RNase. References Elkayam, E., Kuhn, C., Tocilj, A., Haase, A. D., Greene, E. M., Hannon, G. J., Joshua-Tor, L. (2012). The Structure of Human Argonaute-2 in Complex with miR-20a. Cell 150: 100-110. Ender, C., Meister, G. (2010). Argonaute Proteins at a Glance. Journal of Cell Science. 123: 1819-1823. Kuhn, C., Joshua-Tor, L. (2013). Eukaryotic Argonautes come into focus. Trends in Biochemical Sciences. 38(5): 263-271. Kwak, P.B., Tomari, Y. (2012). The N Domain of Argonaute drives duplex unwinding during RISC assembly. Nature Structural and Molecular Biology. 19(2): 145-151. Aldoaldoz. (2010, April 10). Euclid Icosahedron 3. Retrieved February 24, 2015, from https://commons.wikimedia.org/wiki/File:Euclid_Icosahedron_3.svg